US equities
|
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
NVDA
$217.94
▲+0.90%
TSLA
$407.46
▲+4.04%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
NVDA
$217.94
▲+0.90%
TSLA
$407.46
▲+4.04%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Matthew Sykes
Recent news which mentions Matthew Sykes
Goldman Sachs Turns Bullish On Biotech With 'Significant Opportunity'
May 23, 2023
Tickers
QTRX
Tags
QTRX
Trading Ideas
Expert Ideas
From
Benzinga
InVitae's 'Long, Uncertain Path' Toward Profitability: Analyst Downgrades Biotech
January 31, 2023
Tickers
NVTA
Tags
Benzinga
NVTA
Price Target
From
Benzinga